Judge Won't Toss $950M COVID-19 Vax Trade Secrets Row
By Andrew Karpan · August 1, 2022, 5:23 PM EDT
A Seattle federal judge has ruled that it's too soon to decide whether an Indian generic-drug maker can use its minimal connections to the U.S. to ditch a $950 million suit over allegedly stolen trade secrets from a small...
To view the full article, register now.